Home/Filings/4/0001628280-25-010718
4//SEC Filing

BOYER ANDREW S 4

Accession 0001628280-25-010718

CIK 0001723128other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 8:18 PM ET

Size

30.1 KB

Accession

0001628280-25-010718

Insider Transaction Report

Form 4
Period: 2025-03-03
BOYER ANDREW S
Executive Vice President
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-0349,69499,389 total
    Class A Common Stock (49,694 underlying)
  • Exercise/Conversion

    Performance-Based Restricted Stock Units

    2025-03-03157,0050 total
    Class A Common Stock (157,005 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-03-03+39,251315,555 total
  • Tax Payment

    Class A Common Stock

    2025-03-03$8.76/sh20,077$175,875295,478 total
  • Exercise/Conversion

    Class A Common Stock

    2025-03-03+49,694345,172 total
  • Tax Payment

    Class A Common Stock

    2025-03-03$8.76/sh25,419$222,670319,753 total
  • Exercise/Conversion

    Class A Common Stock

    2025-03-03+157,005476,758 total
  • Tax Payment

    Class A Common Stock

    2025-03-03$8.76/sh80,309$703,507396,449 total
  • Exercise/Conversion

    Class A Common Stock

    2025-03-04+38,194434,643 total
  • Tax Payment

    Class A Common Stock

    2025-03-04$8.84/sh19,537$172,707415,106 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-0339,25139,252 total
    Class A Common Stock (39,251 underlying)
  • Award

    Performance-Based Restricted Stock Units

    2025-03-03+194,064194,064 total
    Class A Common Stock (194,064 underlying)
  • Award

    Restricted Stock Units

    2025-03-03+97,03297,033 total
    Class A Common Stock (97,032 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-0438,194114,582 total
    Class A Common Stock (38,194 underlying)
Footnotes (11)
  • [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
  • [F10]The restricted stock units vest in four equal annual installments beginning on March 3, 2026.
  • [F11]On March 4, 2024, the Reporting Person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
  • [F4]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
  • [F5]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
  • [F6]On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
  • [F7]On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
  • [F8]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F9]Represents a performance-based restricted stock unit grant of 97,032 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2028, the last day of the performance period.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001239546

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:18 PM ET
Size
30.1 KB